Pharma Deals Review, Vol 2009, No 11 (2009)

Font Size:  Small  Medium  Large

Novartis Sets Eyes on Chinese Vaccine Market

Taskin Ahmed

Abstract


Swiss drug maker, Novartis is to pay US$125 M to acquire 85% of the Chinese vaccine manufacturer, Zhejiang Tianyuan, in its bid to build a strong presence in China.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.